Catalent Inc
CTLT.N- Latest Trade
- trading lower108.13USD
- Change
- -1.91
- % Change
1.74%Negative
- As of Aug 10 2022. Values delayed up to 15 minutes
- Day Range
- 107.78 - 110.21
- 52-Week Range
- 86.38 - 142.46
- Previous Close
- 110.04
- Open
- 110.11
- Volume
- 195,385.00
- 3 Month Average Trading Volume
- 21.68
- Shares Out (Mil)
- 179.21
- Market Cap
- 19,720.63
- Forward P/E
- 29.24
- Dividend Yield
- -99,999.99
Key Statistics
1.6875 mean rating - 16 analysts
- P/E Excl. Extra Items (TTM)
- 39.62
- Price To Sales (TTM)
- 4.19
- Price To Book (Quarterly)
- 4.25
- Price To Cash Flow (Per Share TTM)
- 23.54
- Total Debt/Total Equity (Quarterly)
- 90.37
- Long Term Debt/Equity (Quarterly)
- 89.75
- Return On Investment (TTM)
- 6.07
- Return On Equity (TTM)
- 5.38
2021 (millions USD)
About Catalent Inc (CTLT.N)
Company Information
Catalent, Inc. provides delivery technologies, and development and manufacturing solutions for drugs; protein, cell, and gene therapy biologics; and consumer health products. Its segments include Softgel and Oral Technologies, Biologics, Oral and Specialty Delivery, and Clinical Supply Services. The Softgel and Oral Technologies segment is engaged in providing formulation, development, and manufacturing services for soft capsules, as well as largescale manufacturing of oral solid dose forms. The Biologics segment provides biologic cell-line, cell therapy and viral vector gene therapy development and manufacturing services. The Oral and Specialty Delivery segment provides formulation development and manufacturing across a range of technologies along with integrated downstream clinical development and commercial supply solutions. The Clinical Supply Services segment is engaged in manufacturing, packaging, distribution and inventory management for drugs and biologics in clinical trials.
Address
14 Schoolhouse RdSOMERSET, NJ
08873-1213
United States
Industry
Biotechnology & Drugs
Executive Leadership
- John R. Chiminski
- Executive Chairman of the Board
- Alessandro Maselli
- President, Chief Executive Officer, Director
- Thomas P. Castellano
- Chief Financial Officer, Senior Vice President
- Aristippos Gennadios
- Group President - Pharma and Consumer Health
- Ricky W. Hopson
- President, Head - Clinical Development & Supply
- Ricci Whitlow
- President - Clinical Supply Services
- Ricardo Pravda
- Chief Human Resource Officer, Senior Vice President
- Steven L. Fasman
- Executive Vice President, Chief Administrative Officer, Interim General Counsel
- Charles Lickfold
- Senior Vice President, Chief Information Officer
- Jonathan Arnold
- Senior Vice President, Chief Commercial Officer, Head of Transformation
- Michael J. Grippo
- Senior Vice President - Strategy and Corporate Development
- Scott Gunther
- Senior Vice President - Quality & Regulatory Affairs
- Kay Schmidt
- Senior Vice President - Technical Operations
- Z Mahdavi
- Vice President of Open Innovation, Biologics, Cell and Gene Therapy
- Jack L. Stahl
- Lead Independent Director
- Madhavan Balachandran
- Independent Director
- Michael J. Barber
- Independent Director
- J. Martin Carroll
- Independent Director
- Rolf A. Classon
- Independent Director
- Rosemary A. Crane
- Independent Director
- John J. Greisch
- Independent Director
- Christa Kreuzburg
- Independent Director
- Gregory T. Lucier
- Independent Director
- Donald E. Morel
- Independent Director
- Peter Zippelius
- Independent Director
Latest News
- MarketsCedar Fair, PG&E Corp, Chevron Corp
U.S. stocks rose in choppy trading on Tuesday, extending gains from the past two sessions, as focus turned to Google parent Alphabet's earnings later in the day.
- BusinessU.S. RESEARCH ROUNDUP Cognition Therapeutics, Mosaic, Shockwave Medical
Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Cognition Therapeutics, Mosaic and Shockwave Medical on Wednesday.
Markets Performance
Official Data PartnerCommodities
| Future | Last | % Change |
|---|---|---|
| Gold | 1,794.00 | -- |
| Copper | 663.00 | 0.05%Positive |
| Brent Crude Oil | 96.17 | 0.15%Negative |
| CBOT Soybeans | 1,693.25 | -- |
Stocks
| Index | Last | % Change |
|---|---|---|
| S&P 500 | 4,122.47 | 0.42%Negative |
| Euro STOXX 50 | 3,715.37 | 1.11%Negative |
| FTSE 100 | 7,488.15 | 0.08%Positive |
| Nikkei 225 | 27,999.96 | -- |
Source: Refinitiv, an LSEG business - data delayed by at least 15 minutes